Doi Kent, Yuen Peter S T, Eisner Christoph, Hu Xuzhen, Leelahavanichkul Asada, Schnermann Jürgen, Star Robert A
National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD 20892-1268, USA.
J Am Soc Nephrol. 2009 Jun;20(6):1217-21. doi: 10.1681/ASN.2008060617. Epub 2009 Apr 23.
Although diagnosis and staging of acute kidney injury uses serum creatinine, acute changes in creatinine lag behind both renal injury and recovery. The risk for mortality increases when acute kidney injury accompanies sepsis; therefore, we sought to explore the limitations of serum creatinine in this setting. In mice, induction of sepsis by cecal ligation and puncture in bilaterally nephrectomized mice increased markers of nonrenal organ injury and serum TNF-alpha. Serum creatinine, however, was significantly lower in septic animals than in animals subjected to bilateral nephrectomy and sham cecal ligation and puncture. Under these conditions treatment with chloroquine decreased nonrenal organ injury markers but paradoxically increased serum creatinine. Sepsis dramatically decreased production of creatinine in nephrectomized mice, without changes in body weight, hematocrit, or extracellular fluid volume. In conclusion, sepsis reduces production of creatinine, which blunts the increase in serum creatinine after sepsis, potentially limiting the early detection of acute kidney injury. This may partially explain why small absolute increases in serum creatinine levels are associated with poor clinical outcomes. These data support the need for new biomarkers that provide better measures of renal injury, especially in patients with sepsis.
尽管急性肾损伤的诊断和分期采用血清肌酐,但肌酐的急性变化在肾损伤和恢复两方面均滞后。当急性肾损伤伴有脓毒症时,死亡风险会增加;因此,我们试图探究在这种情况下血清肌酐的局限性。在小鼠中,通过对双侧肾切除的小鼠进行盲肠结扎和穿刺来诱导脓毒症,会增加非肾器官损伤标志物和血清肿瘤坏死因子-α。然而,脓毒症小鼠的血清肌酐显著低于接受双侧肾切除及假盲肠结扎和穿刺的小鼠。在这些条件下,用氯喹治疗可降低非肾器官损伤标志物,但反常地增加了血清肌酐。脓毒症显著降低了肾切除小鼠的肌酐生成,而体重、血细胞比容或细胞外液量均无变化。总之,脓毒症会降低肌酐生成,这会抑制脓毒症后血清肌酐的升高,可能会限制急性肾损伤的早期检测。这可能部分解释了为什么血清肌酐水平的小幅绝对升高与不良临床结局相关。这些数据支持需要新的生物标志物来更好地衡量肾损伤,尤其是在脓毒症患者中。